IMPACT OF FEMALE DONOR ON ALLOGENEIC STEM CELL TRANSPLANTATION OUTCOME OF MALE RECIPIENT AFTER T-CELL DEPLETION BY RABBIT ANTITHYMOCYTE GLOBULIN

被引：0
|
作者：
Calmettes, C. [1 ]
Vigouroux, S. [1 ]
Tabrizi, R. [1 ]
Pigneux, A. [1 ,2 ]
Leguay, T. [1 ]
Bouabdallah, K. [1 ]
Dilhuydy, M. -S. [1 ]
Duclos, C. [1 ]
Lascaux, A. [1 ]
Dumas, P. -Y. [1 ]
Dimicoli-Salazar, S. [1 ]
Marit, G. [1 ,2 ]
Milpied, N. [1 ,3 ]
机构：
[1] CHU Bordeaux, Hematol & Therapie Cellulaire, Bordeaux, France
[2] Univ Bordeaux Segalen, Bordeaux, France
[3] Univ Bordeaux Segalen, Hematol & Therapie Cellulaire, Bordeaux, France
来源：
BONE MARROW TRANSPLANTATION | 2014年 / 49卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
PH-P380
引用
收藏
页码：S281 / S282
页数：2
相关论文
共 50 条
  • [21] Does T-cell depletion have a future in allogeneic stem cell transplantation?
    de Witte, T. M.
    LEUKEMIA RESEARCH, 2008, 32 (09) : 1354 - 1355
  • [22] Tecelac as antithymocyte globulin in conditioning for childhood allogeneic stem cell transplantation
    Zimmermann, SY
    Klingebiel, T
    Koehl, U
    Soerensen, J
    Schwabe, D
    BONE MARROW TRANSPLANTATION, 2002, 29 (12) : 957 - 962
  • [23] Outcomes of Allogeneic Stem Cell Transplantation with Individualized Dosing of Antithymocyte Globulin
    Keruakous, Amany R.
    Selby, George
    Schmidt, Sarah A.
    Holter-Chakrabarty, Jennifer
    Khawandanah, Mohamad O.
    Steward, Jennifer
    Day, Silas
    Yuen, Carrie
    BLOOD, 2020, 136
  • [24] T-cell depletion in allogeneic stem cell transplantation for myelofibrosis: the Swiss experience
    Casini, A.
    Andres, M.
    Gerull, S.
    Masouridi, S.
    Mohty, B.
    Bucher, C.
    Stern, M.
    Roosnek, E.
    Nair, G.
    Schanz, U.
    Passweg, J.
    Chalandon, Y.
    BONE MARROW TRANSPLANTATION, 2012, 47 : S312 - S312
  • [25] Is there a difference in the disease risk index for outcome of patients undergoing allogeneic haematopoietic stem cell transplantation after T-cell depletion?
    Beauverd, Y.
    Roosnek, E.
    Tirefort, Y.
    Nagy-Hulliger, M.
    Bernimoulin, M.
    Tsopra, O.
    Kindler, V.
    Ansari, M.
    Dantin, C.
    Casini, A.
    Grandjean, A-P
    Chigrinova, E.
    Masouridi-Levrat, S.
    Chalandon, Y.
    BONE MARROW TRANSPLANTATION, 2013, 48 : S251 - S251
  • [26] Tecelac as antithymocyte globulin in conditioning for childhood allogeneic stem cell transplantation
    SY Zimmermann
    T Klingebiel
    U Koehl
    J Soerensen
    D Schwabe
    Bone Marrow Transplantation, 2002, 29 : 957 - 962
  • [27] Impact of T-cell depletion on outcome of patients undergoing allogeneic hematopoietic cell transplantation for myelodysplastic syndrome
    Raboud, Maude
    Beauverd, Yan
    Simonetta, Federico
    Dantin, Carole
    Pradier, Amandine
    Tsopra, Olga
    Koutsi, Aikaterini
    Mamez, Anne-Claire
    Stephan, Caroline
    Morales, Juan Felipe Rodriguez
    Polchlopek-Blasiak, Karolina
    Tirefort, Yordanka
    Masouridi-Levrat, Stavroula
    Chalandon, Yves
    BONE MARROW TRANSPLANTATION, 2018, 53 (08) : 1072 - 1075
  • [28] Impact of T-cell depletion on outcome of patients undergoing allogeneic hematopoietic cell transplantation for myelodysplastic syndrome
    Maude Raboud
    Yan Beauverd
    Federico Simonetta
    Carole Dantin
    Amandine Pradier
    Olga Tsopra
    Aikaterini Koutsi
    Anne-Claire Mamez
    Caroline Stephan
    Juan Felipe Rodriguez Morales
    Karolina Polchlopek-Blasiak
    Yordanka Tirefort
    Stavroula Masouridi-Levrat
    Yves Chalandon
    Bone Marrow Transplantation, 2018, 53 : 1072 - 1075
  • [29] Impact of CD8+ T-cell dose on GvhD after antithymocyte globulin (ATG)-based reduced-intensity conditioning (RIC) for allogeneic stem cell transplantation
    Mohty, M
    Faucher, C
    Bagattini, S
    Bardou, V
    Bilger, K
    Gaugler, B
    Chabannon, C
    Ladaique, P
    Lemarie, C
    Vey, N
    Gastaut, JA
    Maraninchi, D
    Olive, D
    Blaise, D
    BONE MARROW TRANSPLANTATION, 2004, 33 : S181 - S181
  • [30] Improved outcome after T-cell depleted allogeneic hematopoietic stem cell transplantation for myelofibrosis
    Simonetta, F.
    Casini, A.
    Wilk, M.
    Ecsedi, M.
    Andres, M.
    Gerull, S.
    Masouridi-Levrat, S.
    Beauverd, Y.
    Mohty, B.
    Bucher, C.
    Stern, M.
    Manz, M.
    Nair, G.
    Schanz, U.
    Passweg, J.
    Chalandon, Y.
    BONE MARROW TRANSPLANTATION, 2016, 51 : S292 - S292
12345